In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Input: Consider Input: SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Keeping Families 
Together Act of 2001''.
    (b) Table of Contents.--The table of contents of this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Restoration of definition of aggravated felony (repeal of 
                            section 321 of IIRIRA).
Sec. 3. Restoration of detention policy.
Sec. 4. Repeal of time stop provisions.
Sec. 5. Repeal of section 101(a)(48).
Sec. 6. Restoration of section 212(c).
Sec. 7. Restoration of judicial review provisions.
Sec. 8. Post-proceeding relief for affected aliens.

SEC. 2. RESTORATION OF DEFINITION OF AGGRAVATED FELONY (REPEAL OF 
              SECTION 321 OF IIRIRA).

    (a) In General.--Effective as if included in the enactment of the 
Illegal Immigration Reform and Immigrant Responsibility Act of 1996 
(division C of Public Law 104-208), section 321 of such Act is repealed 
and the provisions of law amended by such section are restored as if 
such section had not been enacted.
    (b) Restoration of Rights.--Any alien whose legal permanent 
resident status, application for permanent residence, or application 
for cancellation of removal, was affected by the changes in the 
definition of ``aggravated felony'' made by such section 321 may apply 
to the Attorney General to be considered for adjustment of status or 
cancellation of removal in conformance with the provisions of section 
101(a)(43) of the Immigration and Nationality Act, as restored by 
subsection (a).

SEC. 3. RESTORATION OF DETENTION POLICY.

    (a) In General.--Section 236(c) of the Immigration and Nationality 
Act (8 U.S.C. 1226(c)) is amended to read as follows:
    ``(c) Detention of Criminal Aliens.--
            ``(1) In general.--The Attorney General shall take into 
        custody any alien convicted of an aggravated felony upon 
        release of the alien (regardless of whether or not such release 
        is on parole, supervised release, or probation, and regardless 
        of the possibility of rearrest or further confinement in 
        respect of the same offense). Notwithstanding subsection (a) or 
        section 241(a) but subject to paragraph (2), the Attorney 
        General shall not release such felon from custody.
            ``(2) Non-release.--The Attorney General may not release 
        from custody any who has been convicted of an aggravated 
        felony, either before or after a determination of removability, 
        unless--
                    ``(A)(i) the alien was lawfully admitted, or
                    ``(ii) the alien was not lawfully admitted but the 
                alien cannot be removed because the designated country 
                of removal will not accept the alien; and
                    ``(B) the alien satisfies the Attorney General that 
                the alien will not pose a danger to the safety of other 
                persons or of property and is likely to appear for any 
                scheduled proceeding.''.
    (b) Effective Date.--The amendment made by subsection (a) shall be 
effective as if included in the Illegal Immigration Reform and 
Immigrant Responsibility Act of 1996.

SEC. 4. REPEAL OF TIME STOP PROVISIONS.

    (a) In General.--Section 240A(d) of the Immigration and Nationality 
Act (8 U.S.C. 1229b(d)) is repealed.
    (b) Effective Date.--The repeal made by subsection (a) shall be 
effective as if included in the enactment of subtitle A of title III of 
the Illegal Immigration Reform and Immigrant Responsibility Act of 
1996.

SEC. 5. REPEAL OF SECTION 101(A)(48).

    (a) In General.--Paragraph (48) of section 101(a)(48) of the 
Immigration and Nationality Act (8 U.S.C. 1101(a)) is repealed.
    (b) Effective Date.--The repeal made by subsection (a) shall take 
effect as if included in the enactment of section 322(a) of the Illegal 
Immigration Reform and Immigrant Responsibility Act of 1996.

SEC. 6. RESTORATION OF SECTION 212(C).

    (a) In General.--Section 212 of the Immigration and Nationality Act 
(8 U.S.C. 1182) is amended by inserting after subsection (b) the 
following new subsection:
    ``(c) Aliens lawfully admitted for permanent residence who 
temporarily proceeded abroad voluntarily and not under an order of 
deportation or removal, and who are returning to a lawful 
unrelinquished domicile of seven consecutive years, may be admitted in 
the discretion of the Attorney General without regard to the provisions 
of subsection (a) (other than paragraphs (3) and (10)(C)). Nothing 
contained in this subsection shall limit the authority of the Attorney 
General to exercise the discretion vested in him under section 211(b). 
The first sentence of this subsection shall not apply to an alien who 
has been convicted of one or more aggravated felonies and has served 
for such felony or felonies a term of imprisonment of at least 5 
years.''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
as of April 24, 1996, as if section 440(d) of the Antiterrorism and 
Effective Death Penalty Act of 1996 (Public Law 104-132) and section 
304(b) of Illegal Immigration Reform and Immigrant Responsibility Act 
of 1996 (division C of Public Law 104-208) had not been enacted.

SEC. 7. RESTORATION OF JUDICIAL REVIEW PROVISIONS.

    (a) In General.--Section 242 of the Immigration and Nationality Act 
(8 U.S.C. 1252) is amended to read as follows:

                 ``judicial review of orders of removal

    ``Sec. 242. (a) The procedure prescribed by, and all the provisions 
of chapter 158 of title 28, United States Code, shall apply to, and 
shall be the sole and exclusive procedure for, the judicial review of 
all final orders of removal heretofore or hereafter made against aliens 
within the United States pursuant to administrative proceedings under 
section 240 of this Act or comparable provisions of any prior Act, 
except that--
            ``(1) a petition for review may be filed not later than 90 
        days after the date of the issuance of the final removal order, 
        or, in the case of an alien convicted of an aggravated felony 
        not later than 30 days after the issuance of such order;
            ``(2) the venue of any petition for review under this 
        section shall be in the judicial circuit in which the 
        administrative proceedings before an immigration judge were 
        conducted in whole or in part, or in the judicial circuit 
        wherein is the residence, as defined in this Act, of the 
        petitioner, but not in more than one circuit;
            ``(3) the action shall be brought against the Immigration 
        and Naturalization Service, as respondent. Service of the 
        petition to review shall be made upon the Attorney General of 
        the United States and upon the official of the Immigration and 
        Naturalization Service in charge of the Service district in 
        which the office of the clerk of the court is located. The 
        service of the petition for review upon such official of the 
        Service shall stay the removal of the alien pending 
        determination of the petition by the court, unless the court 
        otherwise directs or unless the alien is convicted of an 
        aggravated felony, in which case the Service shall not stay the 
        removal of the alien pending determination of the petition of 
        the court unless the court otherwise directs;
            ``(4) except as provided in clause (B) of paragraph (5) of 
        this subsection, the petition shall be determined solely upon 
        the administrative record upon which the removal order is based 
        and the Attorney General's findings of fact, if supported by 
        reasonable, substantial, and probative evidence on the record 
        considered as a whole, shall be conclusive;
            ``(5) whenever any petitioner, who seeks review of an order 
        under this section, claims to be a national of the United 
        States and makes a showing that his claim is not frivolous, the 
        court shall (A) pass upon the issues presented when it appears 
        from the pleadings and affidavits filed by the parties that no 
        genuine issue of material fact is presented; or (B) where a 
        genuine issue of material fact as to the petitioner's 
        nationality is presented, transfer the proceedings to a United 
        States district court for the district where the petitioner has 
        his residence for hearing de novo of the nationality claim and 
        determination as if such proceedings were originally initiated 
        in the district court under the provisions of section 2201 of 
        title 28, United States Code. Any such petitioner shall not be 
        entitled to have such issue determined under section 360(a) of 
        this Act or otherwise;
            ``(6) whenever a petitioner seeks review of an order under 
        this section, any review sought with respect to a motion to 
        reopen or reconsider such an order shall be consolidated with 
        the review of the order;
            ``(7) if the validity of a removal order has not been 
        judicially determined, its validity may be challenged in a 
        criminal proceeding against the alien for violation of 
        subsection (a) or (b) of section 243 of this Act only by 
        separate motion for judicial review before trial. Such motion 
        shall be determined by the court without a jury and before the 
        trial of the general issue. Whenever a claim to United States 
        nationality is made in such motion, and in the opinion of the 
        court, a genuine issue of material fact as to the alien's 
        nationality is presented, the court shall accord him a hearing 
        de novo on the nationality claim and determine that issue as if 
        proceedings had been initiated under the provisions of section 
        2201 of title 28, United States Code. Any such alien shall not 
        be entitled to have such issue determined under section 360(a) 
        of this Act or otherwise. If no such hearing de novo as to 
        nationality is conducted, the determination shall be made 
        solely upon the administrative record upon which the removal 
        order is based and the Attorney General's findings of fact, if 
        supported by reasonable, substantial, and probative evidence on 
        the record considered as a whole, shall be conclusive. If the 
        removal order is held invalid, the court shall dismiss the 
        indictment and the United States shall have the right to appeal 
        to the court of appeals within 30 days. The procedure on such 
        appeals shall be as provided in the Federal rules of criminal 
        procedure. No petition for review under this section may be 
        filed by any alien during the pendency of a criminal proceeding 
        against such alien for violation of subsection (a) or (b) of 
        section 243 of this Act;
            ``(8) nothing in this section shall be construed to require 
        the Attorney General to defer removal of an alien after the 
        issuance of a removal order because of the right of judicial 
        review of the order granted by this section, or to relieve any 
        alien from compliance with subsections (a) and (b) of section 
        243 of this Act. Nothing contained in this section shall be 
        construed to preclude the Attorney General from detaining or 
        continuing to detain an alien or from taking the alien into 
        custody pursuant to section 241 of this Act at any time after 
        the issuance of a removal order;
            ``(9) it shall not be necessary to print the record or any 
        part thereof, or the briefs, and the court shall review the 
        proceedings on a typewritten record and on typewritten briefs; 
        and
            ``(10) any alien held in custody pursuant to an order of 
        removal may obtain judicial review thereof by habeas corpus 
        proceedings.
    ``(b) Notwithstanding the provisions of any other law, any alien 
against whom a final order of removal has been made heretofore or 
hereafter under the provisions of section 235 of this Act or comparable 
provisions of any prior Act may obtain judicial review of such order by 
habeas corpus proceedings and not otherwise.
    ``(c) An order of removal shall not be reviewed by any court if the 
alien has not exhausted the administrative remedies available to the 
alien as of right under the immigration laws and regulations or if the 
alien has departed from the United States after the issuance of the 
order. Every petition for review or for habeas corpus shall state 
whether the validity of the order has been upheld in any prior judicial 
proceeding, and, if so, the nature and date thereof, and the court in 
which such proceeding took place. No petition for review or for habeas 
corpus shall be entertained if the validity of the order has been 
previously determined in any civil or criminal proceeding, unless the 
petition presents grounds which the court finds could not have been 
presented in such prior proceeding, or the court finds that the remedy 
provided by such prior proceeding was inadequate or ineffective to test 
the validity of the order.
    ``(d)(1) A petition for review or for habeas corpus on behalf of an 
alien against whom a final order of removal has been issued pursuant to 
section 238(b) may challenge only--
            ``(A) whether the alien is in fact the alien described in 
        the order;
            ``(B) whether the alien is in fact an alien described in 
        section 238(b)(2);
            ``(C) whether the alien has been convicted of an aggravated 
        felony and such conviction has become final; and
            ``(D) whether the alien was afforded the procedures 
        required by section 238(b)(4).
    ``(2) No court shall have jurisdiction to review any issue other 
than an issue described in paragraph (1).''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect on the date of the enactment of this Act and shall apply to 
determinations pending on or after such date with respect to which--
            (1) a final administrative decision has been not been 
        rendered as of such date; or
            (2) such a decision has been rendered but the period for 
        seeking judicial review of the decision has not expired.

SEC. 8. POST-PROCEEDING RELIEF FOR AFFECTED ALIENS.

    (a) In General.--Notwithstanding section 240(c)(6) of the 
Immigration and Nationality Act (8 U.S.C. 1229a(c)(6)) or any other 
limitation imposed by law on motions to reopen removal proceedings, the 
Attorney General shall establish a process (whether through permitting 
the reopening of a removal proceeding or otherwise) under which an 
alien--
            (1) who is (or was) in removal proceedings before the date 
        of the enactment of this Act (whether or not the alien has been 
        removed as of such date); and
            (2) whose eligibility for cancellation of removal has been 
        established by this Act;
may apply (or reapply) for cancellation of removal under section 
240A(a) of the Immigration and Nationality Act (8 U.S.C. 1229b(a)) as a 
beneficiary of the relief provided under this Act.
    (b) Parole.--The Attorney General should exercise the parole 
authority under section 212(d)(5)(A) of the Immigration and Nationality 
Act (8 U.S.C. 1182(d)(5)(A)) for the purpose of permitting aliens 
removed from the United States to participate in the process 
established under subsection (a).

Output: Keeping Families Together Act of 2001 - Amends the Illegal Immigration Reform and Immigrant Responsibility Act of 1996 (Act) to repeal the provision amending the definition of "aggravated felony," and restore provisions of law amended by such provision as if it had not been enacted, including residency-or status-related rights of an affected legal alien. Amends the Immigration and Nationality Act to revise detention of criminal alien provisions, effective as if included in the Act. Repeals, as if included in the Act: (1) certain provisions respecting termination of continuous presence or physical presence in the United States; and (2) the definition of "conviction."Authorizes the Attorney General to admit certain lawfully admitted permanent resident aliens returning to the United States who temporarily proceeded abroad voluntarily and not under an order of deportation or removal, effective as of a specified date, as if certain sections of the Antiterrorism and Effective Death Penalty Act of 1996 and the Illegal Immigration Reform and Immigrant Responsibility Act of 1996 had not been enacted. Revises provisions respecting judicial review of removal orders.Requires the Attorney General to establish a post-proceeding removal relief process for affected aliens.


Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Cancer Screening and Prevention 
Act''.

SEC. 2. MEDICARE COVERAGE OF COLORECTAL SCREENING.

    (a) In General.--Section 1834 of the Social Security Act (42 U.S.C. 
1395m) is amended by inserting after subsection (c) the following new 
subsection:
    ``(d) Frequency and Payment Limits for Screening Fecal-Occult Blood 
Tests, Screening Flexible Sigmoidoscopies, and Screening Colonoscopy.--
            ``(1) Screening fecal-occult blood tests.--
                    ``(A) Payment limit.--In establishing fee schedules 
                under section 1833(h) with respect to screening fecal-
                occult blood tests provided for the purpose of early 
                detection of colon cancer, except as provided by the 
                Secretary under paragraph (3)(A), the payment amount 
                established for tests performed--
                            ``(i) in 1996 shall not exceed $5; and
                            ``(ii) in a subsequent year, shall not 
                        exceed the limit on the payment amount 
                        established under this subsection for such 
                        tests for the preceding year, adjusted by the 
                        applicable adjustment under section 1833(h) for 
                        tests performed in such year.
                    ``(B) Frequency limit.--Subject to revision by the 
                Secretary under paragraph (3)(B), no payment may be 
                made under this part for a screening fecal-occult blood 
                test provided to an individual for the purpose of early 
                detection of colon cancer--
                            ``(i) if the individual is under 50 years 
                        of age; or
                            ``(ii) if the test is performed within the 
                        11 months after a previous screening fecal-
                        occult blood test.
            ``(2) Screening flexible sigmoid- oscopies.--
                    ``(A) Payment amount.--The Secretary shall 
                establish a payment amount under section 1848 with 
                respect to screening flexible sigmoidoscopies provided 
                for the purpose of early detection of colon cancer that 
                is consistent with payment amounts under such section 
                for similar or related services, except that such 
                payment amount shall be established without regard to 
                subsection (a)(2)(A) of such section.
                    ``(B) Frequency limit.--Subject to revision by the 
                Secretary under paragraph (4)(B), no payment may be 
                made under this part for a screening flexible 
                sigmoidoscopy provided to an individual for the purpose 
                of early detection of colon cancer--
                            ``(i) if the individual is under 50 years 
                        of age; or
                            ``(ii) if the procedure is performed within 
                        the 47 months after a previous screening 
                        flexible sigmoidoscopy.
            ``(3) Screening colonoscopy for individuals at high risk 
        for colorectal cancer.--
                    ``(A) Payment amount.--The Secretary shall 
                establish a payment amount under section 1848 with 
                respect to screening colonoscopy for individuals at 
                high risk for colorectal cancer (as defined in 
                subparagraph (C)) provided for the purpose of early 
                detection of colon cancer that is consistent with 
                payment amounts under such section for similar or 
                related services, except that such payment amount shall 
                be established without regard to subsection (a)(2)(A) 
                of such section.
                    ``(B) Frequency limit.--Subject to revision by the 
                Secretary under paragraph (4)(B), no payment may be 
                made under this part for a screening colonoscopy for 
                individuals at high
                 risk for colorectal cancer provided to an individual 
for the purpose of early detection of colon cancer if the procedure is 
performed within the 23 months after a previous screening colonoscopy.
                    ``(C) Individual at high risk defined.--In this 
                subsection, an `individual at high risk for colorectal 
                cancer' is an individual who, because of family 
                history, prior experience of cancer or precursor 
                neoplastic polyps, a history of chronic digestive 
                disease condition (including inflammatory bowel 
                disease, Crohn's Disease, or ulcerative colitis), the 
                presence of any appropriate recognized gene markers for 
                colorectal cancer, or other predisposing factors, faces 
                a high risk for colorectal cancer.
            ``(4) Reductions in payment limit and revision of 
        frequency.--
                    ``(A) Reductions in payment limit.--The Secretary 
                shall review from time to time the appropriateness of 
                the amount of the payment limit established for 
                screening fecal-occult blood tests under paragraph 
                (1)(A). The Secretary may, with respect to tests 
                performed in a year after 1998, reduce the amount of 
                such
                 limit as it applies nationally or in any area to the 
amount that the Secretary estimates is required to assure that such 
tests of an appropriate quality are readily and conveniently available 
during the year.
                    ``(B) Revision of frequency.--
                            ``(i) Review.--The Secretary shall review 
                        periodically the appropriate frequency for 
                        performing screening fecal-occult blood tests, 
                        screening flexible sigmoidoscopies, and 
                        screening colonoscopy based on age and such 
                        other factors as the Secretary believes to be 
                        pertinent.
                            ``(ii) Revision of frequency.--The 
                        Secretary, taking into consideration the review 
                        made under clause (i), may revise from time to 
                        time the frequency with which such tests and 
                        procedures may be paid for under this 
                        subsection, but no such revision shall apply to 
                        tests or procedures performed before January 1, 
                        1999.
            ``(5) Limiting charges of nonparticipating physicians.--
                    ``(A) In general.--In the case of a screening 
                flexible sigmoidoscopy provided to an individual for 
                the purpose of early detection of colon cancer or a 
                screening colonoscopy provided to an individual at high 
                risk for colorectal cancer for the purpose of early 
                detection of colon cancer for which payment may be made 
                under this part, if a nonparticipating physician 
                provides the procedure to an individual enrolled under 
                this part, the physician may not charge the individual 
                more than the limiting charge (as defined in section 
                1848(g)(2)).
                    ``(B) Enforcement.--If a physician or supplier 
                knowing and willfully imposes a charge in violation of 
                subparagraph (A), the Secretary may apply sanctions 
                against such physician or supplier in accordance with 
                section 1842(j)(2).''.
    (b) Conforming Amendments.--(1) Paragraphs (1)(D) and (2)(D) of 
section 1833(a) of such Act (42 U.S.C. 1395l(a)) are each amended by 
striking ``subsection (h)(1),'' and inserting ``subsection (h)(1) or 
section 1834(d)(1),''.
    (2) Section 1833(h)(1)(A) of such Act (42 U.S.C. 1395l(h)(1)(A)) is 
amended by striking ``The Secretary'' and inserting ``Subject to 
paragraphs (1) and (3)(A) of section 1834(d), the Secretary''.
    (3) Clauses (i) and (ii) of section 1848(a)(2)(A) of such Act (42 
U.S.C. 1395w-4(a)(2)(A)) are each amended by striking ``a service'' and 
inserting ``a service (other than a screening flexible sigmoidoscopy 
provided to an individual for the purpose of early detection of colon 
cancer or a screening colonoscopy provided to an individual at high 
risk for colorectal cancer for the purpose of early detection of colon 
cancer)''.
    (4) Section 1862(a) of such Act (42 U.S.C. 1395y(a)) is amended--
            (A) in paragraph (1)--
                    (i) in subparagraph (E), by striking ``and'' at the 
                end,
                    (ii) in subparagraph (F), by striking the semicolon 
                at the end and inserting ``, and'', and
                    (iii) by adding at the end the following new 
                subparagraph:
            ``(G) in the case of screening fecal-occult blood tests, 
        screening flexible sigmoidoscopies, and screening colonoscopy 
        provided for the purpose of early detection of colon cancer, 
        which are performed more frequently than is covered under 
        section 1834(d);''; and
            (B) in paragraph (7), by striking ``paragraph (1)(B) or 
        under paragraph (1)(F)'' and inserting ``subparagraphs (B), 
        (F), or (G) of paragraph (1)''.

SEC. 3. EFFECTIVE DATE.

    The amendments made by section 2 shall apply to screening fecal-
occult blood tests, screening flexible sigmoidoscopies, and screening 
colonoscopy performed on or after January 1, 1996.

Output: Cancer Screening and Prevention Act - Amends title XVIII (Medicare) of the Social Security Act to provide for coverage of various specified colon and colorectal screening tests and corresponding payment and frequency limits.


Input: Consider Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Heroin and Prescription Opioid Abuse 
Prevention, Education, and Enforcement Act of 2015.''.

SEC. 2. FINDINGS.

    Congress makes the following findings:
            (1) The Controlled Substances Act (21 U.S.C. 801 et seq.) 
        declares that many controlled substances have a useful and 
        legitimate medical purpose and are necessary to maintain the 
        health and general welfare of the people of the United States.
            (2) Health care professionals, medical experts, 
        researchers, and scientists have found pain to be a major 
        national health problem.
            (3) The responsible treatment of pain is a high priority 
        for our Nation and the needs of individuals with pain must be 
        taken into careful consideration when taking steps to prevent 
        prescription drug misuse and abuse.
            (4) When no longer needed or wanted for legitimate pain 
        management or health treatment, prescription opioids are 
        susceptible to diversion. Prescription opioids also may be 
        abused by individuals who were not prescribed such drugs, or 
        misused by individuals not taking such drugs as directed.
            (5) Approximately 4 out of 5 new heroin users report that 
        they became addicted to prescription opioids before they used 
        heroin for the first time.
            (6) According to the National Institute on Drug Abuse, 
        heroin attaches to the same brain cell receptors as 
        prescription opioids.
            (7) The low cost and high purity of currently available 
        heroin has contributed to an increase in heroin use across the 
        United States.
            (8) More people are using heroin, and are using heroin at a 
        younger age. The National Survey on Drug Use and Health reports 
        that new heroin users numbered 142,000 in 2010, and increased 
        to 178,000 in 2011. In 2011, the average age at first use among 
        heroin abusers between 12 and 49 years was 22.1 years. In 2009, 
        the average age at first use among heroin abusers between 12 
        and 49 years was 25.5 years.
            (9) According to the Department of Health and Human 
        Services, heroin use nationwide rose 79 percent between 2007 
        and 2012.
            (10) Deaths from heroin overdose have significantly 
        increased in communities across the United States. According to 
        the Centers for Disease Control and Prevention, the number of 
        deaths involving heroin almost tripled between 2010 and 2013. 
        From 2010 to 2013, the number of heroin deaths rose from 3,036 
        to 8,257.
            (11) The Edward Byrne Memorial Justice Assistance Grant 
        Program under part E of title I of the Omnibus Crime Control 
        and Safe Streets Act of 1968 (42 U.S.C. 3750 et seq.) is 
        critical to fighting the prescription opioid abuse and heroin 
        use epidemics, and should be reauthorized and fully funded.

SEC. 3. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.

    (a) Inter-Agency Task Force.--Not later than 120 days after the 
date of enactment of this Act, the Secretary of Health and Human 
Services (referred to in this section as the ``Secretary''), in 
cooperation with the Secretary of Veterans Affairs, the Secretary of 
Defense, and the Administrator of the Drug Enforcement Administration, 
shall convene a Pain Management Best Practices Inter-Agency Task Force 
(referred to in this section as the ``task force'').
    (b) Membership.--The task force shall be comprised of--
            (1) representatives of--
                    (A) the Department of Health and Human Services, 
                including the Centers for Disease Control and 
                Prevention;
                    (B) the Department of Veterans Affairs;
                    (C) the Department of Defense;
                    (D) the Drug Enforcement Administration;
                    (E) the Office of National Drug Control Policy; and
                    (F) the Institute of Medicine;
            (2) the Director of the National Institutes of Health;
            (3) physicians, dentists, and non-physician prescribers;
            (4) pharmacists;
            (5) experts in the fields of pain research and addiction 
        research;
            (6) representatives of--
                    (A) pain management professional organizations;
                    (B) the mental health treatment community;
                    (C) the addiction treatment community; and
                    (D) pain advocacy groups; and
            (7) other stakeholders, as the Secretary determines 
        appropriate.
    (c) Duties.--The task force shall--
            (1) not later than 180 days after the date on which the 
        task force is convened, develop best practices for pain 
        management and prescription pain medication prescribing 
        practices, taking into consideration--
                    (A) existing pain management research;
                    (B) recommendations from relevant conferences; and
                    (C) ongoing efforts at the State and local levels 
                and by medical professional organizations to develop 
                improved pain management strategies;
            (2) solicit and take into consideration public comment on 
        the best practices developed under paragraph (1), amending such 
        best practices if appropriate; and
            (3) develop a strategy for disseminating information about 
        the best practices developed under paragraphs (1) and (2) to 
        prescribers, pharmacists, State medical boards, and other 
        parties, as the Secretary determines appropriate.
    (d) Limitation.--The task force shall not have rulemaking 
authority.
    (e) Report.--Not later than 270 days after the date on which the 
task force is convened under subsection (a), the task force shall 
submit to Congress a report that includes--
            (1) the strategy for disseminating best practices developed 
        under subsection (c);
            (2) the results of a feasibility study on linking best 
        practices developed under paragraphs (1) and (2) of subsection 
        (c) to receiving and renewing registrations under section 
        303(f) of the Controlled Substances Act (21 U.S.C. 823(f)); and
            (3) recommendations on how to apply such best practices to 
        improve prescribing practices at medical facilities, including 
        medical facilities of the Veterans Health Administration.

SEC. 4. HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM.

    (a) Authorization of Appropriations.--To carry out the Harold 
Rogers Prescription Drug Monitoring Program established under the 
Departments of Commerce, Justice, and State, the Judiciary, and Related 
Agencies Appropriations Act, 2002 (Public Law 107-77; 115 Stat. 748), 
there is authorized to be appropriated $9,000,000 for each of fiscal 
years 2016 through 2020.
    (b) GAO Report.--Not later than 1 year after the date of enactment 
of this Act, the Comptroller General of the United States shall submit 
to Congress a report evaluating the effectiveness of the Harold Rogers 
Prescription Drug Monitoring Program in reducing prescription drug 
abuse, and, to the extent practicable, any corresponding increase or 
decrease in the use of heroin.

SEC. 5. REAUTHORIZATION OF BYRNE JUSTICE ASSISTANCE GRANT PROGRAM.

    Section 508 of title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (42 U.S.C. 3758) is amended by striking ``2006 
through 2012'' and inserting ``2016 through 2020''.

SEC. 6. AWARENESS CAMPAIGNS.

    (a) In General.--The Secretary of Health and Human Services shall 
advance the education and awareness of the public, providers, patients, 
and other appropriate stakeholders regarding the risk of abuse of 
prescription opioid drugs if such products are not taken as prescribed.
    (b) Drug-Free Media Campaign.--
            (1) In general.--The Office of National Drug Control 
        Policy, in coordination with the Secretary of Health and Human 
        Services and the Attorney General, shall establish a national 
        drug awareness campaign.
            (2) Requirements.--The national drug awareness campaign 
        under paragraph (1) shall--
                    (A) take into account the association between 
                prescription opioid abuse and heroin use;
                    (B) emphasize the similarities between heroin and 
                prescription opioids and the effects of heroin and 
                prescription opioids on the human body; and
                    (C) bring greater public awareness to the dangerous 
                effects of fentanyl when mixed with heroin or abused in 
                a similar manner.
            (3) Available funds.--Funds for the national drug awareness 
        campaign may be derived from amounts appropriated to the Office 
        of National Drug Control Policy and otherwise available for 
        obligation and expenditure.

SEC. 7. NALOXONE DEMONSTRATION GRANTS.

    (a) Definitions.--In this section--
            (1) the term ``eligible entity'' means a State, a unit of 
        local government, or a tribal government;
            (2) the term ``first responder'' includes firefighters, law 
        enforcement officers, paramedics, emergency medical 
        technicians, and other individuals (including employees of 
        legally organized and recognized volunteer organizations, 
        whether compensated or not), who, in the course of professional 
        duties, respond to fire, medical, hazardous material, or other 
        similar emergencies; and
            (3) the term ``opioid overdose reversal drug'' means a drug 
        that, when administered, reverses in whole or part the 
        pharmacological effects of an opioid overdose in the human 
        body.
    (b) Program Authorized.--The Attorney General, in coordination with 
the Secretary of Health and Human Services and the Director of the 
Office of National Drug Control Policy, may make grants to eligible 
entities to create not more than 8 demonstration programs to allow 
properly trained first responders to prevent prescription opioid and 
heroin overdose death by administering an opioid overdose reversal drug 
to an individual who has experienced overdose or who has been 
determined to have likely experienced overdose.
    (c) Application.--
            (1) In general.--To be eligible to receive a grant under 
        this section, an entity shall submit an application to the 
        Attorney General, at such time, in such manner, and accompanied 
        by such information as the Attorney General shall require, 
        and--
                    (A) that meets the criteria for selection under 
                paragraph (2); and
                    (B) that describes--
                            (i) the evidence-based methodology and 
                        outcome measures that will be used to evaluate 
                        the program funded with a grant under this 
                        section, and specifically explain how such 
                        measurements will provide valid measures of the 
                        impact of the program;
                            (ii) how the program could be broadly 
                        replicated if demonstrated to be effective;
                            (iii) how the eligible entity will 
                        coordinate with their corresponding State 
                        substance abuse agency to identify protocols 
                        and resources that are available to victims and 
                        families, including information on treatment 
                        and recovery resources; and
                            (iv) how the demonstration program will 
                        continue with State, local, or private funding 
                        after the expiration of the grant.
            (2) Criteria for selection.--The Attorney General may award 
        grants to eligible entities that demonstrate an institutional 
        need for technical support and lack existing infrastructure in 
        order to implement and train first responders to carry out a 
        demonstration program under paragraph (b).
            (3) Priority consideration.--In awarding grants under this 
        section, the Attorney General shall give priority to an 
        eligible entity located in a State that provides civil 
        liability protection for first responders administering an 
        opioid overdose reversal drug to counteract opioid overdoses 
        by--
                    (A) enacting legislation that provides such civil 
                liability protection; and
                    (B) providing a certification by the attorney 
                general of the State that the attorney general has--
                            (i) reviewed any applicable civil liability 
                        protection law to determine the applicability 
                        of the law with respect to first responders who 
                        may administer an opioid overdose reversal drug 
                        to individuals reasonably believed to be 
                        suffering from opioid overdose; and
                            (ii) concluded that the law described in 
                        subparagraph (A) provides adequate civil 
                        liability protection applicable to such 
                        persons.
    (d) Use of Funds.--An eligible entity shall use a grant received 
under this section to--
            (1) make an opioid overdose reversal drug, which may 
        include naloxone, available to be carried and administered by 
        first responders;
            (2) train and provide resources for first responders, on 
        carrying and administrating such opioid overdose reversal drug 
        for the prevention of prescription opioid and heroin overdose 
        deaths; and
            (3) establish processes, protocols, and mechanisms for 
        referral to treatment.
    (e) Technical Support.--The Attorney General shall provide 
individualized technical support, as requested, to grant recipients 
under this section to assist with implementation of the demonstration 
program.
    (f) Grant Duration.--A demonstration project grant shall be for a 
period of 3 years.
    (g) Evaluation.--Following the first grant year, a recipient of a 
grant awarded under this section shall report to the Attorney General 
on an annual basis --
            (1) the number of first responders equipped with an opioid 
        overdose reversal drug for the prevention of fatal prescription 
        opioid and heroin overdose;
            (2) the number of prescription opioid and heroin overdoses 
        reversed by first responders;
            (3) the number of calls for service related to prescription 
        opioid and heroin overdose; and
            (4) the extent to which overdose victims and families 
        receive information about treatment services and available data 
        describing treatment admissions.
    (h) Report to Congress.--The Attorney General shall submit an 
annual report to the appropriate committees of Congress aggregating the 
data received from the grant recipients and evaluating the outcomes 
achieved by the demonstration projects funded under this section.

SEC. 8. OFFSET.

    It is the sense of Congress that the amounts expended to carry out 
this Act and the amendments made by this Act should be offset by a 
corresponding reduction in Federal non-defense discretionary spending.


Output: Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015 This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration, to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication. The Harold Rogers Prescription Drug Monitoring Program is extended through FY2020. The Government Accountability Office must evaluate the effectiveness of this program in reducing prescription drug abuse and any corresponding increase or decrease in the use of heroin. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020. HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium). The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the Department of Justice (DOJ), must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids and increases awareness of the dangerous effects of mixing fentanyl (a prescription opioid painkiller) with heroin. DOJ, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone). Priority must be given to entities in states that provide civil liability protection for first responders administering a drug to counteract opioid overdoses.